Medicated Skin Care in Saudi Arabia
Euromonitor International's Medicated Skin Care in Saudi Arabia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 25 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
OTC HEALTHCARE IN SAUDI ARABIA : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 5 OTC Healthcare Switches
Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - SAUDI ARABIA
GLAXO SAUDI ARABIA LTD - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Glaxo Saudi Arabia Ltd/GlaxoSmithKline: Operational Indicators 2004
PRODUCTION CAPACITY
JULPHAR GULF PHARMACEUTICALS - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Julphar: Operational Indicators 2004
PRODUCTION CAPACITY
SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CO (SPIMACO) - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - SPIMACO: Operational Indicators 2004
PRODUCTION CAPACITY
TABUK PHARMACEUTICAL MANUFACTURING CO - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 4 Summary - Tabuk Pharmaceutical Manufacturing Co: Operational Indicators 2004
PRODUCTION CAPACITY
MEDICATED SKIN CARE IN SAUDI ARABIA
SECTOR PERFORMANCE
2005 headlines
Sales grow at much healthier rate due price increases but growth is hindered by topical germicidals/antiseptics
Demographic factors boost sales of nappy rash and acne treatments
Acne treatment by format
Antipruritics sales overlap with topical allergy remedies/antihistamines
Massive penetration of cosmetic skin care products prevents the development of emollients/therapeutic moisturisers
Medicated shampoos is most dynamic in 2005 because of strategic price change for Nizoral
Highly fragmented sector with little movement in shares
Reckitt Benckiser maintains leadership and share thanks to continued support of Dettol
Glaxo second, marginal decline in its share of 2005
Janssen Cilag regains share in 2005 because of price increase of Nizoral
Forecast performance: Same healthy performance to continue
Table 12 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 14 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 15 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 16 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 17 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Herbal-based medicated skin care products are very minimal due to high prices
Table 18 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Multinational brands dominate sales but face increased threats from newcomers
Table 19 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Table 20 Hair Loss Treatments Brand Shares by Retail Value 2002-2005